242 related articles for article (PubMed ID: 26254030)
1. Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies.
Collaborative Group on Epidemiological Studies on Endometrial Cancer
Lancet Oncol; 2015 Sep; 16(9):1061-1070. PubMed ID: 26254030
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls.
; Beral V; Doll R; Hermon C; Peto R; Reeves G
Lancet; 2008 Jan; 371(9609):303-14. PubMed ID: 18294997
[TBL] [Abstract][Full Text] [Related]
3. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study.
Iversen L; Sivasubramaniam S; Lee AJ; Fielding S; Hannaford PC
Am J Obstet Gynecol; 2017 Jun; 216(6):580.e1-580.e9. PubMed ID: 28188769
[TBL] [Abstract][Full Text] [Related]
4. Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers.
Karlsson T; Johansson T; Höglund J; Ek WE; Johansson Å
Cancer Res; 2021 Feb; 81(4):1153-1162. PubMed ID: 33334812
[TBL] [Abstract][Full Text] [Related]
5. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
Petitti DB; Porterfield D
Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
[TBL] [Abstract][Full Text] [Related]
6. Contemporary hormonal contraception and risk of endometrial cancer in women younger than age 50: A retrospective cohort study of Danish women.
Iversen L; Fielding S; Lidegaard Ø; Hannaford PC
Contraception; 2020 Sep; 102(3):152-158. PubMed ID: 32592798
[TBL] [Abstract][Full Text] [Related]
7. Oral contraceptives and endometrial cancer: do other risk factors modify the association?
Stanford JL; Brinton LA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Hoover RN
Int J Cancer; 1993 May; 54(2):243-8. PubMed ID: 8486426
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptives and breast disease.
McGonigle KF; Huggins GR
Fertil Steril; 1991 Nov; 56(5):799-819. PubMed ID: 1936311
[TBL] [Abstract][Full Text] [Related]
9. Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study.
Colditz GA
Ann Intern Med; 1994 May; 120(10):821-6. PubMed ID: 8154642
[TBL] [Abstract][Full Text] [Related]
10. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study.
Urban M; Banks E; Egger S; Canfell K; O'Connell D; Beral V; Sitas F
PLoS Med; 2012; 9(3):e1001182. PubMed ID: 22412354
[TBL] [Abstract][Full Text] [Related]
11. [Oral contraceptives and endometrial and ovarian carcinomas].
Medl M
Gynakol Geburtshilfliche Rundsch; 1998; 38(2):105-8. PubMed ID: 9815528
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptives and breast cancer risk among younger women.
Brinton LA; Daling JR; Liff JM; Schoenberg JB; Malone KE; Stanford JL; Coates RJ; Gammon MD; Hanson L; Hoover RN
J Natl Cancer Inst; 1995 Jun; 87(11):827-35. PubMed ID: 7791232
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptives and breast, endometrial, and ovarian cancers. The Cancer and Steroid Hormone Study Group, Atlanta Georgia.
Gwinn ML
J Obstet Gynaecol (Lahore); 1985 Jan; 5 Suppl 2():S83-7. PubMed ID: 12268773
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptives and gynecologic cancer: an update for the 1990s.
Kaunitz AM
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1171-6. PubMed ID: 1415442
[TBL] [Abstract][Full Text] [Related]
15. Noncontraceptive health benefits of oral steroidal contraceptives.
Mishell DR
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):809-16. PubMed ID: 7065059
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of endometrial cancer in young women.
Henderson BE; Casagrande JT; Pike MC; Mack T; Rosario I; Duke A
Br J Cancer; 1983 Jun; 47(6):749-56. PubMed ID: 6860544
[TBL] [Abstract][Full Text] [Related]
17. [The risk of breast cervical, endometrial and ovarian cancer in oral contraceptive users].
Veljković M; Veljković S
Med Pregl; 2010; 63(9-10):657-61. PubMed ID: 21446095
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies.
Collaborative Group on Hormonal Factors in Breast Cancer
Lancet; 1996 Jun; 347(9017):1713-27. PubMed ID: 8656904
[TBL] [Abstract][Full Text] [Related]
19. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
20. Endometrial and ovarian cancer and oral contraceptives--findings in a large cohort study.
Vessey MP; Painter R
Br J Cancer; 1995 Jun; 71(6):1340-2. PubMed ID: 7779735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
